+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
FEMALE
ID06445946

Comparing Oral Metformin and Injectable Insulin Treatments for Gestational Diabetes Mellitus in Pregnancy

Led by Ohio State University · Updated on 2026-10-07

1572

Participants Needed

26

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of oral metformin compared to injectable insulin in treating gestational diabetes mellitus GDM in pregnant individuals. This phase 4, randomized controlled trial aims to determine whether metformin is not worse than insulin in reducing adverse pregnancy outcomes and to assess patient-reported experiences and long-term safety for both mothers and their children. The study involves 1,572 pregnant individuals with GDM requiring medication, recruited from 20 U.S. sites, with follow-up through delivery and up to two years postpartum. Participants are randomly assigned to one of two treatment groups the metformin group or the insulin group. Those in the metformin group will take oral metformin tablets, either immediate- or extended-release, up to a maximum daily dose of 2,500 mg, with insulin added if needed due to insufficient blood sugar control or intolerance. The insulin group will receive injectable insulin, which may include basal and prandial insulins, with dosing adjusted by trimester and weight, following clinical standards. Treatments reflect usual clinical practice, and the trial is open-label without masking. Throughout the study, participants and their children will be monitored with evaluations including pregnancy outcomes, neonatal health, and child growth up to two years of age. Assessments will include maternal health measures such as hypertensive disorders, weight gain, delivery method, and metabolic profiles, as well as child body mass index and other growth indicators. Patient-reported outcomes will be collected at six weeks and two years postpartum. Safety and treatment satisfaction will be tracked, with data collected during routine care and scheduled follow-up visits.

CONDITIONS

Brief Title

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Research Team

K

Kartik Venkatesh, MD, PhD

A

Anna Bartholomew, MPH, BS, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here